2017 Q1 Form 10-Q Financial Statement

#000156459017009955 Filed on May 09, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q1
Revenue $20.33M $27.19M
YoY Change -25.22% 2.94%
Cost Of Revenue $8.324M $9.190M
YoY Change -9.42% -5.35%
Gross Profit $12.01M $18.00M
YoY Change -33.28% 7.75%
Gross Profit Margin 59.06% 66.19%
Selling, General & Admin $10.85M $14.08M
YoY Change -22.9% -21.26%
% of Gross Profit 90.37% 78.21%
Research & Development $7.138M $8.009M
YoY Change -10.88% -5.6%
% of Gross Profit 59.44% 44.5%
Depreciation & Amortization $2.124M $2.346M
YoY Change -9.46% 8.01%
% of Gross Profit 17.69% 13.03%
Operating Expenses $17.99M $22.09M
YoY Change -18.54% -16.22%
Operating Profit -$5.982M -$4.087M
YoY Change 46.37% -57.68%
Interest Expense -$40.00K -$20.00K
YoY Change 100.0% 100.0%
% of Operating Profit
Other Income/Expense, Net $299.0K $33.00K
YoY Change 806.06% -86.48%
Pretax Income -$5.720M -$4.072M
YoY Change 40.47% -56.79%
Income Tax $406.0K $341.0K
% Of Pretax Income
Net Earnings -$6.126M -$4.413M
YoY Change 38.82% -54.32%
Net Earnings / Revenue -30.13% -16.23%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.099M -$816.7K
COMMON SHARES
Basic Shares Outstanding 39.25M
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q1 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $33.00M $36.20M
YoY Change -8.84% -31.44%
Cash & Equivalents $34.29M $36.20M
Short-Term Investments
Other Short-Term Assets $6.500M $4.200M
YoY Change 54.76% -30.0%
Inventory
Prepaid Expenses
Receivables $15.90M $23.90M
Other Receivables $0.00 $0.00
Total Short-Term Assets $55.50M $64.30M
YoY Change -13.69% -18.32%
LONG-TERM ASSETS
Property, Plant & Equipment $19.20M $21.20M
YoY Change -9.43% 25.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.600M $1.300M
YoY Change 23.08% 74.5%
Total Long-Term Assets $46.70M $51.70M
YoY Change -9.67% 3.24%
TOTAL ASSETS
Total Short-Term Assets $55.50M $64.30M
Total Long-Term Assets $46.70M $51.70M
Total Assets $102.2M $116.0M
YoY Change -11.9% -9.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.400M $1.400M
YoY Change 71.43% -73.54%
Accrued Expenses $6.300M $10.50M
YoY Change -40.0% 1.94%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.000M $900.0K
YoY Change 11.11% -71.8%
Total Short-Term Liabilities $12.20M $15.90M
YoY Change -23.27% -29.46%
LONG-TERM LIABILITIES
Long-Term Debt $2.100M $1.400M
YoY Change 50.0% 914.49%
Other Long-Term Liabilities $4.400M $4.600M
YoY Change -4.35% 105.45%
Total Long-Term Liabilities $6.500M $6.000M
YoY Change 8.33% 152.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.20M $15.90M
Total Long-Term Liabilities $6.500M $6.000M
Total Liabilities $18.80M $21.90M
YoY Change -14.16% -12.11%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $83.40M $94.10M
YoY Change
Total Liabilities & Shareholders Equity $102.2M $116.0M
YoY Change -11.9% -9.94%

Cashflow Statement

Concept 2017 Q1 2016 Q1
OPERATING ACTIVITIES
Net Income -$6.126M -$4.413M
YoY Change 38.82% -54.32%
Depreciation, Depletion And Amortization $2.124M $2.346M
YoY Change -9.46% 8.01%
Cash From Operating Activities -$780.0K $600.0K
YoY Change -230.0% -115.87%
INVESTING ACTIVITIES
Capital Expenditures $169.0K $267.0K
YoY Change -36.7% -88.6%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$710.0K -$1.760M
YoY Change -59.66% -83.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -110.0K -100.0K
YoY Change 10.0% -64.29%
NET CHANGE
Cash From Operating Activities -780.0K 600.0K
Cash From Investing Activities -710.0K -1.760M
Cash From Financing Activities -110.0K -100.0K
Net Change In Cash -1.421M -1.260M
YoY Change 12.78% -91.45%
FREE CASH FLOW
Cash From Operating Activities -$780.0K $600.0K
Capital Expenditures $169.0K $267.0K
Free Cash Flow -$949.0K $333.0K
YoY Change -384.98% -105.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 us-gaap Cost Of Revenue
CostOfRevenue
9190000
CY2017Q1 us-gaap Cost Of Revenue
CostOfRevenue
8324000
CY2017Q1 us-gaap Gross Profit
GrossProfit
12009000
CY2016Q1 us-gaap Gross Profit
GrossProfit
17998000
CY2017Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6676000
CY2016Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9107000
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7138000
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8009000
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4177000
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4969000
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
17991000
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
22085000
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5982000
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4087000
CY2017Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-37000
CY2016Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-18000
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
299000
CY2016Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
33000
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5720000
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4072000
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
406000
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
341000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-6126000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-4413000
CY2017Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
219000
CY2016Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
425000
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5907000
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3988000
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39081000
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
37767000
CY2017Q1 us-gaap Depreciation
Depreciation
1336000
CY2016Q1 us-gaap Depreciation
Depreciation
1665000
CY2017Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
788000
CY2016Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
681000
CY2017Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
730000
CY2016Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
826000
CY2017Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
1000
CY2016Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1000
CY2017Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
12000
CY2016Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-7000
CY2017Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
6000
CY2016Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
7000
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1842000
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3822000
CY2017Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
416000
CY2016Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
195000
CY2017Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
18000
CY2016Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
0
CY2017Q1 mrin Payment Of Contingent Consideration For Prior Acquisition
PaymentOfContingentConsiderationForPriorAcquisition
0
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2439000
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2204000
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1418000
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
0
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-711000
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1760000
CY2017Q1 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-249000
CY2016Q1 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-646000
CY2016Q1 mrin Payment Of Contingent Consideration For Prior Acquisition
PaymentOfContingentConsiderationForPriorAcquisition
93000
CY2017Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1000
CY2016Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
6000
CY2017Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-49000
CY2016Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-331000
CY2017Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
167000
CY2016Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
122000
CY2017Q1 mrin Increase Decrease In Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccruedExpensesAndOtherLiabilities
-915000
CY2016Q1 mrin Increase Decrease In Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccruedExpensesAndOtherLiabilities
323000
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-778000
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
602000
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
169000
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
267000
CY2017Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1000
CY2016Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
CY2017Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
543000
CY2016Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1493000
CY2017Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2016Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
162000
CY2017Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
136000
CY2016Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
384000
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-113000
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-100000
CY2017Q1 mrin Effect Of Exchange Rate On Cash And Cash Equivalents And Restricted Cash Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsAndRestrictedCashContinuingOperations
181000
CY2016Q1 mrin Effect Of Exchange Rate On Cash And Cash Equivalents And Restricted Cash Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsAndRestrictedCashContinuingOperations
169000
CY2017Q1 mrin Cash And Cash Equivalents And Restricted Cash Period Increase Decrease
CashAndCashEquivalentsAndRestrictedCashPeriodIncreaseDecrease
-1421000
CY2016Q1 mrin Cash And Cash Equivalents And Restricted Cash Period Increase Decrease
CashAndCashEquivalentsAndRestrictedCashPeriodIncreaseDecrease
-1089000
CY2016Q4 mrin Cash And Cash Equivalents And Restricted Cash At Carrying Value
CashAndCashEquivalentsAndRestrictedCashAtCarryingValue
35713000
CY2015Q4 mrin Cash And Cash Equivalents And Restricted Cash At Carrying Value
CashAndCashEquivalentsAndRestrictedCashAtCarryingValue
37326000
CY2017Q1 mrin Cash And Cash Equivalents And Restricted Cash At Carrying Value
CashAndCashEquivalentsAndRestrictedCashAtCarryingValue
34292000
CY2016Q1 mrin Cash And Cash Equivalents And Restricted Cash At Carrying Value
CashAndCashEquivalentsAndRestrictedCashAtCarryingValue
36237000
CY2017Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2006-03-31
CY2017Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3597000
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3510000
CY2017Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
1759000
CY2016Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
1947000
CY2017Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2016Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2017Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
57646000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
57125000
CY2017Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
38471000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
36544000
CY2017Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2124000
CY2016Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2346000
CY2017Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3279000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3894000
CY2017Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2037000
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1915000
CY2017Q1 us-gaap Customer Advances Current
CustomerAdvancesCurrent
1506000
CY2016Q4 us-gaap Customer Advances Current
CustomerAdvancesCurrent
1582000
CY2017Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
223000
CY2016Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
210000
CY2017Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
756000
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
761000
CY2017Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
24000
CY2017Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
14670000
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
14670000
CY2017Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8075000
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7345000
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2120000
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2537000
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1843000
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
95000
CY2017Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
853000
CY2017Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo
1078000
CY2017Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree
886000
CY2017Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour
345000
CY2017Q1 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
3162000
CY2017Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
8000
CY2017Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
15975000
CY2016Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
14281000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3749000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
490000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3259000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2173000
CY2017Q1 mrin Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingNumber
2171000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
3200000
CY2017Q1 mrin Share Based Compensation Arrangement By Share Based Payment Award Options Vested Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedPeriodWeightedAverageExercisePrice
7.67
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
6.41
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y5M23D
CY2017Q1 mrin Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Remaining Contractual Term Two Forfeited Or Cancelled
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermTwoForfeitedOrCancelled
P0Y
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y4M6D
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y1M10D
CY2017Q1 mrin Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm
P5Y1M10D
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y3M18D
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
194000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
57000
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
57000
CY2017Q1 mrin Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue
57000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
57000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
3003000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.26
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
5.60
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.36
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.67
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
328000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
165000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
622000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2544000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
3.07
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.81
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8452000
CY2017Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2017Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2017Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2080000
CY2016Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2168000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
4.20
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
3.01
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.85
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2017Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1440000
CY2017Q1 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
0
CY2017Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0
CY2017Q1 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
0
CY2017Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2016Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5807000
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
4562000
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
4442000
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
4016000
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
3338000
CY2017Q1 mrin Operating Leases Future Minimum Payments Due In Five Years And Thereafter
OperatingLeasesFutureMinimumPaymentsDueInFiveYearsAndThereafter
5994000
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
22352000
CY2016Q4 us-gaap Litigation Reserve
LitigationReserve
0
CY2017Q1 us-gaap Litigation Reserve
LitigationReserve
0

Files In Submission

Name View Source Status
0001564590-17-009955-index-headers.html Edgar Link pending
0001564590-17-009955-index.html Edgar Link pending
0001564590-17-009955.txt Edgar Link pending
0001564590-17-009955-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
mrin-10q_20170331.htm Edgar Link pending
mrin-20170331.xml Edgar Link completed
mrin-20170331.xsd Edgar Link pending
mrin-20170331_cal.xml Edgar Link unprocessable
mrin-20170331_def.xml Edgar Link unprocessable
mrin-20170331_lab.xml Edgar Link unprocessable
mrin-20170331_pre.xml Edgar Link unprocessable
mrin-ex311_8.htm Edgar Link pending
mrin-ex312_7.htm Edgar Link pending
mrin-ex321_6.htm Edgar Link pending
mrin-ex322_11.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending